:

  1. #51
      Ya-
    . - .
    09.07.2011
    42
    6,027
    , , , . ( )
       

  2. #52
      never give up
    21.09.2012
    103

    Ya-
    ,
       

  3. #53

    23.09.2010
    ,
    47
    26,606

    , , , .

    , . , .
    - .

    , - S100, , , . , , . - , , , .

    S-100 - - , (36 ). 1980 Fagerhol . [9], " L1". . 60% , , .
    - , 6 , [2]. - .



    , "" ≤ 50 / [10]. , , 50 / [2].
    , . , . [11] , . 50 / 89% ( ) ( ) 81%, 98% 91% () 100 /. , 50-100 /.
    , 150 / , 100% 97% [2]. .
    , 10 [2], , 1 .


    . , , .

    - . , , , [3].


    :
    1. A. El-Badry, H. Sedrak, and L. Rashed, Faecal Calprotectin in Differentiating between Functional and Organic Bowel Diseases. Arab Journal of Gastroenterology, 2010. 11: p. 70-73.
    2. M.R. Konikoff and L.A. Denson, Role of Fecal Calprotectin as a Biomarker of Intestinal Inflammation in Inflammatory Bowel Disease. Inflamm Bowel Dis, 2006. 12(6).
    3. P.V. Rheenen, E. Van-De-Vijve, and V. Fidler, Faecal Calprotectin for Screening of Patients with Suspected Inflammatory Bowel Disease: Diagnostic Meta-Analysis. BMJ, 2010. 341.
    4. J. Keohane, et al., Irritable Bowel SyndromeType Symptoms in Patients with Inflammatory Bowel Disease: A Real Association or Reflection of Occult Inflammation. The American Journal of Gastroenterology, 2010.
    5. D. Desai, W.A. Faubion, and W.J. Sandborn, Review Article: Biological Activity Markers in Inflammatory Bowel Disease. Aliment Pharmacol Ther, 2007. 25: p. 247-255.
    6. M.C. Dubinsky, et al., Suspected Inflammatory Bowel Disease the Clinical and Economic Impact of Competing Diagnostic Strategies. The American Journal of Gastroenterology, 2002. 97(9).
    7. B.S. Lewis and P. Swain, Capsule Endoscopy in the Evaluation of Patients with Suspected Small Intestinal Bleeding: Results of a Pilot Study. Gastrointestinal Endoscopy, 2002. 56(3): p. 349-353.
    8. B. Vucelic, Inflammatory Bowel Diseases: Controversies in the Use of Diagnostic Procedures. Dig Dis, 2009. 27: p. 269-277.
    9. M.K. Fagerhol, I. Dale, and T. Andersson, Release and Quantitation of a Leucocyte Derived Protein (L1). Scand J Haematol, 1980. 24: p. 39-398.
    10. A. Roseth, et al., Assessment of the Neutrophil Dominating Protein Calprotectin in Feces: A Methodologic Study. Scand J Gastroenterol, 1992. 27: p. 793-798.
    11. A.C.V. Roon, et al., Diagnostic Precision of Fecal Calprotectin for Inflammatory Bowel Disease and Colorectal Malignancy. Am J Gastroenterol, 2007. 102: p. 803-813.
    http://www.medlab.kiev.ua/node/118
       

  4. #54
      Igor_Passau
    12.05.2009
    38
    2,990

    4244.00 - 5. 385.00 7-10
    http://medlab.kiev.ua/price/alphabet
    ! 14 !
    !
    "Fuer einen treuen Freund gibt es keinen Preis, nichts wiegt seinen Wert auf"
       

  5. #55
      1976
    (9 )
    11.10.2010
    .
    42
    1,692

    , 100.
       

  6. #56

    23.09.2010
    ,
    47
    26,606

    50 / , !http://www.medlab.kiev.ua/node/118
    :
    . 50. ? .
    "" ≤ 50 / [10]. , , 50 / [2].
    . [11] , . 50 / 89% ( ) ( ) 81%, 98% 91% () 100 /.
    150 , !
    , 150 / , 100% 97% [2]. .
       

  7. #57

    21.01.2013
    37
    137

    . - , , , . . 10 - , !!
    - 600. , . , ))
       

  8. #58

    23.09.2010
    ,
    47
    26,606

    , .
    !
    .
       

  9. #59

    21.01.2013
    37
    137

    , , , ! - , , . ,
    , - (, ).
       

  10. #60

    23.09.2010
    ,
    47
    26,606

    . , , .
       

,

: 1 (: 0 , : 1)

  •